FUTURE IBD: The emerging role of the IL-23 inhibitor class in Crohn’s disease (AbbVie)

Edouard Louis  1     Laurent Peyrin-Biroulet  2    
1 University Hospital of Liège
2 Nancy University Hospital Inserm U954 Dept. of Hepato-Gastroenterology

Session
FUTURE IBD: The emerging role of the IL-23 inhibitor class in Crohn’s disease (AbbVie)

Conference
UEG Week Virtual 2021

Publisher

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing